Purpose of Review This article reviews the case for recognizing (1) the epidemics of opioid misuse, overdose, hepatitis C virus, and HIV as a syndemic and (2) the importance of examining and addressing structural factors in responses to this syndemic. We focus on the current syndemic in the US, but also consider data from other locations to highlight the issues existing and arising in various contexts. Recent Findings Advances in multi-level theory and statistical methods allow sound ecologic and multi-level analyses of the impact of structural factors on the syndemic. Studies of opioid misuse, overdoses, hepatitis C virus, and HIV demonstrate that area-level access to healthcare, medication-assisted treatment of opioid use disorders, sterile injection equipment, and overdose prevention with naloxone, as well as factors such as opioid marketing, income inequality, intensity of policing activities, and health care policies, are related to the prevalence of substance misuse, overdoses, infection risk, and morbidity. Structural variables can predict area-level vulnerability to the syndemic. The implementation of combined prevention and treatment interventions can control and reverse components of the syndemic. Summary Recognizing and monitoring potent structural factors can facilitate the identification of areas at risk of vulnerability to the syndemic. Further, many structural factors are modifiable through intervention and policy to reduce structural vulnerability and create health-enabling environments. Evidence supports the immediate implementation of broader HCVand HIV testing and substance use screening, medication-assisted treatment, needle/syringe exchange programs, naloxone programs, increased population-level implementation of HCV treatment, and further attention to structural-level factors predicting, and contributing to, area-level vulnerability, such as degrees of opioid marketing, distribution, and prescribing.
Introduction
The United States (US) is in the midst of an epidemic of opioid misuse and its consequences [1] [2] [3] . In fact, the opioid epidemic is probably best viewed as a set of inter-related and overlapping epidemics of the misuse of prescription and illicit opioids, fatal and non-fatal overdoses, and HIV and hepatitis C virus (HCV) transmission [1, [4] [5] [6] [7] [8] . These inter-related epidemics are occurring in communities and areas already marginalized by a range of structural conditions including poverty, de-industrialization, underemployment, and rising inequality [9] [10] [11] [12] [13] [14] [15] . These overlapping epidemics and contextual conditions can productively be viewed as a syndemic, and recognition of this would strengthen optimal public health and policy responses [13, 16, 17] . Further, optimal responses will require recognition of the multi-level forces contributing to the development and perpetuation of the opioid misuse, overdose, HCV, and HIV syndemic [17] [18] [19] [20] [21] .
There is increasing recognition of the importance of what have variously been called supraindividual, social, or structural determinants, or area-or place-based factors, in shaping the epidemiology of health generally and specifically with respect to the components of this syndemic [11, 17, 19, This article is part of the Topical Collection on The Global Epidemic * David C. Perlman david.perlman@mountsinai.org 20, [22] [23] [24] . Area-level access to healthcare, substance use treatment, sterile injection equipment, and overdose prevention (e.g., naloxone), and factors such as income inequality, segregation, degrees of opioid marketing, and mass incarceration and degrees of aggressive policing activities, have all been shown to be related to risk and disease rates and prevalence of drug misuse [23, [25] [26] [27] [28] [29] [30] [31] . Conceptual models and increasing data support an important role of structural factors in shaping the opioid misuse, overdoses, HCV, and HIV epidemics, and point toward a central role of structural-level responses to the syndemic [11] . Factors including the previous underdevelopment of relevant theory, methods, and of training for research and health professionals, and variable and incomplete understandings of the importance of structural health influences by health professionals, general public, and policymakers, have contributed to the under-attention to modifiable structural factors which are driving this syndemic [11, 13] . Structural factors are often important fundamental causes of health outcomes, and are often modifiable factors whose importance should be studied and used to inform public health monitoring, clinical programs, and policies and funding [18, 23, 28] .
We will review (1) the case for recognizing the epidemics of opioid misuse, overdose, HCV, and HIV as a syndemic (referred to here as "the syndemic" or individually as "component(s) of the syndemic") and (2) the importance of examining and addressing structural factors in public health and policy responses to this syndemic. We will briefly review advances in multi-level theory and methods, and then review selected recent work examining a range of structural factors with respect to the components of the syndemic. We will discuss structural factors and interventions that are being, or could be, examined or implemented to: (1) predict components of the syndemic, (2) respond to the syndemic and its components, and (3) prevent future re-emergences these epidemics in the US and elsewhere. We focus on the current syndemic in the US, but also consider data from other locations to highlight the issues existing and arising in various contexts, both because (a) trends toward rising inequality in the US resemble those of low-and middle-income settings and (b) the forces shaping the current US syndemic pose analogous risks to non-US settings that require global public health planning.
Theory and Methods for Examining Structural Influences
A key assumption of standard multivariate analysis is the independence of the outcome variable from all independent variables. When analyses examine group-level independent variables and a group-level outcome (i.e., ecologic studies), the assumptions of independence are generally met and standard multivariate analysis is appropriate [32] . When analyses take into consideration data at two or more levels (i.e., multi-level studies), the assumption of independence is commonly violated (e.g., individual-level income is not the same construct as the median income in that individual's area, but they are not independent) as observations at one level tend to be clustered at another level (e.g., residents are clustered into neighborhoods). If clustering of data is not accounted for, standard errors may be under-or over-estimated [33] . Earlier approaches to handle clustered data included "population average models" which account for correlation between levels and distinguish structural from individual health effects. Multi-level models are powerful approaches to more fully account for the hierarchical relationships between levels of data [32, 33] .
There are a range of multi-level theories to guide research and public health responses [28] . While these theories have some key differences, they share the understanding that forces can operate at multiple levels, and that these forces can act in a variety of ways (e.g., as mediators, or primary causes) to impact outcomes [18, 28, 33] . Two major conceptual frameworks that can help focus attention on multi-level factors relevant to these overlapping epidemics are ecosocial theory and Rhode's social-structural production of substance use-related risk model [21, 28] .
Ecosocial theory provides a framework recognizing the importance of constructs of scale and macro structural factors in the production of risks and disease. It highlights that structural forces should not be viewed as the more "distal" end of a linear path beginning with "proximal" individual-level factors, but must be viewed instead as dialectically interrelated forces [20] . Rhode's model provides an elaboration of this framework conceptualizing the risk environment "as the space-whether social or physical-in which a variety of factors interact to increase the chances of drug-related harm" where important components include movements of populations, area-level deprivation and social capital, legal status of drug use, needle and syringe exchange programs (NSPs) and medication-assisted treatment (MAT) for opioid use disorders (OUD), criminal justice activities, and the impact of "big event" [21, 34] . A key corollary of the concept of a risk environment is that environments may be modified to become health-enabling environments [19] .
Pathways Through Which Structural Variables May Act
Central to the understanding of the importance of structural factors in the production of disease and risk is understanding the pathways through which they may act [22, 35] . (Table 1) . One hypothesized pathway through which structural factors influence outcomes is through impacting individual-level That is, a PWID with any specified level of knowledge of prevention interventions and the motivation and self-efficacy to implement them, may inject in an area of a specified HCV prevalence in which sterile syringes are readily available through legal prevention programs. In contrast, there may be a PWID with the exact same level of information, motivation, and self-efficacy who injects in an area of the same HCV prevalence with no sources of sterile syringes are available as a matter of law, policy, and program. An estimated per-event probability of HCV transmission from an infected to an uninfected PWID of 0.5% results in very different transmission dynamics if that risk event occurs in a region of 0% HCV prevalence or a region of 60% HCV prevalence. In each case, factors external to the individual and independent of individual behavior, impact transmission risk.
a The term structural relates to constructs measured above the individual or social network level and includes factors such as policies or laws, economic measures, as well as other factors that vary as a function of area b The term individual-level refers to characteristics measured at the level of the individual (e.g., genetic, socio-demographic, experiential)
c The Social Vulnerability Index was designed initially for use in disaster management and is a composite measure of 15 variables at the census-tract level d The term supraindividual refers to all constructs measured above the level of the individual; this includes social network factors which refers to interactions between an individual and specific (known or unknown) other individuals e The terms place-based or area-level refers to a subset of structural variables, commonly constructed with data derived for specific geographic units (e.g., zip codes)
factors (e.g., behavior) directly (i.e., the "theory of social comparison") [22] . According to this construction, real and perceived hierarchical social relations may directly cause individual psychologic or biologic responses (e.g., depression) or may directly influence behavior (e.g., increased risk-tasking) [26, 36] . Another hypothesized pathway is that structural factors may act at the social network level, for example, through reducing degrees of social support or, through exchange of skills to navigate systems (i.e., "an erosion of social capital") [21, 23, 37, 38] . Structural factors acting at either the individual or social network level may influence or restrict individual behavioral choices. Structural factors may also influence individual-level outcomes completely independent of individual-level behavior. For example, areas of greater income inequality may receive less government funding which many change environmental factors impacting individual-level health outcomes beyond anything an individual can overcome through changed behavior (Table 1) [22] . A corollary of the fact that structural factors may impact disease rates independent of individual behavior is that some structural forces can only be, or may best be, addressed at the structural-level rather than solely through efforts to change individual behavior.
The Syndemic: Opioid Misuse, Overdose, HCV, and HIV in Contexts Made Vulnerable A syndemic has been defined as "the aggregation of two or more diseases or other health conditions in a population in which there is some level of deleterious biological or behavior interface that exacerbates the negative health effects of any or all of the diseases involved" [16] . These may involve any combination of infectious or non-communicable conditions, as well as the social and environmental conditions within which the epidemics are embedded and interact [12, [39] [40] [41] . Unlike the concept of co-morbidities, syndemic theory considers population-level clusters of health conditions and social problems as occurring and interacting in specific social, temporal, and geographic contexts, which promote the development and inter-relatedness of the conditions [13] .
The specific syndemic we address is that of opioid misuse, overdose, HCV, and HIV. Each health condition has its own epidemiologic trajectory, and each interacts with the others at levels of causes, consequences, and needed responses in context. Prescription opioid misuse has risen sharply since 1990, and overdose deaths have tripled between 1999 and 2015; both are linked temporally with increases in licit opioid marketing, distribution and prescribing, and illicit opioid markets [1, 2, 42, 43] . Further, substance misuse and substance use disorders (SUDs) contribute to significant morbidity and mortality directly and via increases in HCV and HIV transmission [3-5, 42, 44, 45] .
The importance of both the degrees of overlap of the components of the syndemic and of area-level variations in populations and structural variables, has been highlighted by the HIV outbreak in Indiana, and by rural, suburban, and urban outbreaks, often in regions of poverty, high underemployment, and often significant deindustrialization [2, 6, 9, 12, 30, 44, 46, 47] . Many of these settings have limited access to MAT and NSPs and are characterized by local policies which do not adequately promote health-enabling environments. [25] As few as one in ten Americans with SUDs receive any treatment; one third of those who do not, cite cost or lack of health insurance coverage as the reason [48] . MAT is the most efficacious evidence-based treatment for OUDs, yet approximately 10% of substance use treatment facilities in the US offer it [49, 50] . Programs to prevent overdoses (e.g., naloxone training and distribution) have increasingly been implemented [29, 51] . However, as a function of public policy, there is significant variation in the geographic distribution of both naloxone programs and of the availability and coverage of MAT [52, 53] . Further, gaps in the implementation of MAT constitute a structural barrier that has implications for components of the syndemic; for example, lower county-level access to buprenorphine is associated with greater countylevel vulnerability to HCV and HIV epidemics [25] .
It may be for HIV that the literature has most extensively addressed the impact of structural factors and for which structural interventions have been implemented [19-21, 40, 54] . (Table 2 ) Since the beginning of the HIV epidemic, public health responses involved multi-level interventions and combined prevention efforts (NSPs, pharmacy-based syringe access, MAT, HIV and HCV testing, antiretroviral treatment (ART), and condom distribution) have reduced HIV transmission among PWID [67] . These data highlight the important contribution of structural factors to the syndemic, and that multi-level interventions can contain and reverse epidemics [17] .
Prescription Opioid Misuse in the US: Marketing as a Key Structural Factor
The opioid epidemic has involved voluminous marketing, distribution, and prescribing in the licit drug market and evolutions in the illicit drug market [2, 68] . Structural forces that drive markets have long histories. In the mid-nineteenth century, the British waged military operations that have come to be called the "Opium Wars," to force China to allow the sale of opium (which Britain grew in its Indian colony for the express purposes of sale to China) [14, 69] . British traders, backed by their government and military, considered opium marketing a normal trade; however, China banned opium imports and considered the British to be smuggling and creating an illicit drug market, highlighting ongoing important interrelationships between licit and illicit drug markets [15, 70] . British traders developed flavored opium poppy products, to appeal to young people (including children) and develop a long-term market; China experienced a prolonged and major opioid epidemic [70] . These marketing strategies foreshadowed now well-documented efforts by the American tobacco industry to downplay evidence of nicotine dependence and to develop strategies to attract young users.
The marketing of opioids in the US has a similarly checkered history [14] . As late as 1912, Bayer marketed heroin for use in adults and children as a remedy for coughs and colds. By 1899, it produced 1 ton of heroin annually, marketed to 23 countries. Heroin's history as a licit, and then illicit drug over subsequent decades has been well reviewed [14] .
More recently, between the mid-1990s and mid-2000s highly potent oral opioids (with new patents, e.g., oxycodone and fentanyl) were heavily marketed and distributed (which may be considered a "big event") [42, 43] . Marketing focused both on the putative under-treatment of pain and on claims that new formulations had less addictive potential claims that were weak at best, and fraudulent at worst [68] . Campaigns included starter coupons which provided 7-30-day supplies of free OxyContin® [42] . Area-level characteristics were used to direct opioid marketing and distribution, by focusing on areas with active pain clinics and populations with high rates of injuries and disability-related pain [2, 71] . These marketing efforts led to increases in sales of opioids in unequivocal temporal association with the rise of OUDs and overdoses [42] . Marketing efforts and the laws and policies regulating the marketing of licit opioids are important factors in driving opioid epidemics [68] .
HCV: Under-Implementation of Prevention and Treatment
The HCV epidemic historically preceded the HIV epidemic. The combined prevention interventions that have effectively contributed to control of HIV have been less effective in controlling HCV. [45] Reasons include both the underimplementation of NSP and MAT and the higher infectivity of HCV [72] . Further, while the expansion of ART coverage among HIV-infected PWID contributed to reductions in HIV transmission, analogous expansion of HCV treatment remains under-implemented [73, 74] .
The excellent efficacy of current HCV treatment raises the possibility that the expansion of treatment may serve as population-level HCV treatment as prevention (TasP) in a manner analogous to the role of ART as HIV TasP. However, modeling studies suggest that HCV TasP alone is likely to have an incomplete impact on HCV transmission; models suggest that concomitant expansion of structural interventions (i.e., NSP, MAT) is necessary. Many insurers have established criteria to limit access to HCV treatment, often putting in place eligibility restrictions greater than those contained in the Food and Drug Administration (FDA) approval of the drugs and that specifically exclude people who use drugs (PWUD) [75] [76] [77] . Translating the principle of HCV TasP into effective population-level implementation would require that issues of healthcare access, structural stigma associated with substance use, and medication costs be addressed [74] .
Recognition of Structural Vulnerability and Need for Structural Competency
Structural vulnerability is a construct reflecting the vulnerability of a population or a region, to adverse conditions; it is produced by a convergence of structural factors in geographic locations, embedded in existing social conditions [78] . Improved provider-level "structural competency" may facilitate providers' and patients' joint understanding of the importance of accessing concrete services (e.g., social work or patient navigation), and of interventions to increase an individual's ability to manage structural barriers (e.g., increasing selfefficacy) [78] . An analogous need exists for improved structural competency among researchers, public health officials, and policymakers, ensuring their understanding that structural factors are important causes and modifiable factors to be studied and addressed in policy responses to the syndemic. Nonetheless, any individual-level responses to structural forces (while valuable) do not treat the primary cause or remove key mediators; other options exist at the policy-level to more directly address structural barriers.
Predicting Vulnerability to the Syndemic
A wide range of structural factors may be useful as predictors of syndemic risk and be potentially modifiable at the public health and policy-level [19, 20, 54, 68] . (Tables 2 and 3) . A recent analysis found that rising county-level unemployment rates predicted rises in opioid deaths and opioid-related emergency department visits [46] . Van Handel, et al. identified a set of area-level indicators associated with acute HCV infection; indicators included overdose rates, licit prescription opioid sales, buprenorphine capacity, and non-Hispanic white ethnicity. Indicators were used to develop a score reflecting arealevel vulnerability to HIV or HCV outbreaks; 220 counties in 26 states were identified as being within the 95% percentile of the most vulnerable. This vulnerability index serves as one valuable formulation of the construct of structural vulnerability [79] . Note that five of these six predictors of county-level vulnerability were structural factors that are themselves adverse outcomes (low per capita income and buprenorphine Aggregates of census-tract data Table 3 Selected possible responses to modifiable structural factors to address the syndemic and its components Categories (informed by Auerbach et al. [19] ) and examples Policy and legal change Substance misuse and overdoses
• Expanded funding to implement broad substance use screening.
• Expanded funding to implement interventions to improve linkages from substance use screening to medication-assisted treatment (MAT) and to promote retention in care.
• Enforce parity of medical and mental health care (and opioid use disorder (OUD) treatment, which of necessity spans the two) and carefully balance confidentially protections for those with OUDs so as to not adversely affect access and engagement in care.
• Increase access to MAT by Affordable Care Act and other regulatory mandates for insurance to fully cover OUD treatment.
• Funding to expand implementation of OUD treatment in specialty and primary care office-based settings.
• Policies and regulations to ensure that all OUD treatment facilities offer and provide MAT for opioid use disorders.
• Ensure quality of MAT programs (e.g., providing adequate doses).
• Remove barriers to MAT for opioid use disorders in adolescents.
• Funding to implement and ensure adequate access to MAT in correctional settings.
• Funding for training and expanded implementation of naloxone to a wider range including emergency professionals, police, and personal contacts in all geographic areas.
• Stricter Food and Drug Administration (FDA) review of all opioids.
• More rigorous and proactive FDA review of opioid marketing materials and strategies.
• Establish judicious limits for the marketing of all opioids, informed by sound evidence-based practices.
• Policies and legislation to ban the use of free-starter coupons for opioids.
• Build evidence base examining the use of monitoring opioid marketing and distribution data as a public health tool to predict upsurges in licit and illicit opioid misuse, OUDs, and overdoses.
• Regulation of the marketing of OUD treatment (including through social media and search engines) to ensure its basis in evidence.
• Funding to support the expanded implementation and nationwide coordination of Prescription Drug Monitoring Programs and prescribing guidelines.
• Implement pain clinic laws and regulate pain clinics.
HCV and HIV
• Policy changes and funding to expand access to needle/syringe exchange programs (NSPs) in all areas.
• Expanded access to risk factor-based hepatitis C virus (HCV) and HIV testing
• Expanded funding for and implementation of interventions to improve linkages from HCV and HIV testing to care and to promote retention in care.
• Funding to ensure adequate access to HCV treatment and to ensure full insurance coverage of HCV treatment (to allow population-level treatment as prevention), eliminating barriers (such as prior approvals and co-pays) to treatment by insurance plans, regulation of medication pricing, and elimination of Medicare Part D restrictions on regulating prices.
• Funding to implement and ensure adequate access to HCV treatment in correctional settings.
Pan-syndemic
• Funding to further develop and implement use of care continuum models for substance use and HCV, as well as for HIV, to monitor program, regional, and national progress, as well as to clearly convey gaps in implementation to lay audiences and policy makers.
• Regulation and enforcement of policies to promote the greater avoidance of potential conflicts of interest in guideline development (e.g., pain, opioid prescribing, MAT, HCV testing and treatment).
Environmental enablers
• Increase access to MAT in geographic distributions which minimize gaps or disparities.
• Funding to expand implementation of integrated prevention and treatment services which simultaneously address the components of syndemic and their contexts.
• Expand the evidence base for use of safe injection facilities.
Shifting harmful norms
• Create health-enabling environments through accessible destigmatized access to NSPs minimizing deincentivizing adjacent policing activities.
• Decrease structural stigmatization of MAT which serves as a barrier to its broader implementation.
• Funding to expand efforts to destigmatize opioid use, OUDs and NSPs.
Promoting social and political change
• Shift emphasis from criminal justice to public health approaches to opioid misuse. prescribing potential; and high overdose rates, prescription opioid prescribing, and high unemployment). Structural domains not included in this model but that may be relevant to components of the syndemic include housing, criminal justice, economic, and trade [55-59, 64, 65, 80, 81] .
Housing and Criminal Justice
Housing is one factor through which policy and social and economic conditions influence health [80] . Individual-level homelessness is associated with outcomes including overdose, injection and sexual risk, infection transmission, and adverse engagement and retention in both substance use and anti-viral treatments [80] . Neighborhood characteristics, including neighborhood disadvantage, affect the age of initiation of injection drug use (IDU), rates of drug use, and other health outcomes [10, 63, 64, 82] . (Table 2 ) Among PWID in 19 US cities, those living in zip codes with higher levels of gentrification had higher odds of past year homelessness [80] . Another important structural factor impacting this syndemic is criminal justice activity (e.g., incarceration, stop, and frisk) [11, 26, 56, 66, 83] . The US has the world's highest incarceration rates; 3.2% of the population is under some form of correctional control [84, 85] . Criminal justice exposures vary among racial and ethnic groups, and racial/ethnic minorities make up a disproportionate number of those in the correctional system. The health impacts of criminal justice exposures are incompletely delineated with respect to drug use and components of the syndemic [82, 84, 86] , but exposures have been associated with greater individual-level psychological distress, greater HIV risk, and reduced engagement in preventive interventions [36, 87] . PWID reporting prior police stops are less likely to use NSPs consistently, and those who had syringes confiscated are more likely to share syringes [83] . Cooper, et al. found that living in areas with better access to sterile syringes was associated with higher arrest rates, and that adjacent policing activities diminished NSPs' beneficial impact on sterile injection and infection risk [56] .
Area-Level Economic Factors and the Syndemic
Economic inequality has increased in many countries [9] . Data demonstrate potent relationships between area-level economic factors and a variety of health outcomes [22, 59, 88, 89] . As an example, after the dissolution of the Soviet Union, gross domestic product (GDP) fell and unemployment rose, and austerity policies (which mandated social service and health expenditure cuts) were required of several new Eastern European countries by international lenders (Table 1) ; this led to increases in IDU, HIV, HCV, sexually transmitted infections, and tuberculosis [63, 88, 89] .
With respect to HIV, there are significant relationships (1) between rising national income inequality and declining GDP growth rates and increases in HIV diagnoses among PWID in Europe and (2) between increased income inequality and higher HIV-related mortality [59, 73] . A study of the European Economic Area found that decreases in the GDP and two additional measures of income inequality were associated with increases in the odds of an HIV outbreak [34] . (Table 2) . Categories (informed by Auerbach et al. [19] ) and examples
• Develop and implement strategies to coordinate criminal justice activities so as to minimize adverse impacts on prevention interventions such as NSP and MAT. Economic interventions
• Funding to reduce area-level structural vulnerability by addressing regional economic inequality, poverty, underemployment, and under-insurance through policy.
• Federal funding to expand the geographic distribution and capacity of NSPs, and to allow for pharmacy sales of syringes in all jurisdictions.
Structural competency
• Education of health professionals in structural competency, training in evidence-based pain management and office-based MAT.
• Expansion of training and use of naloxone to wider range including emergency professionals, police, as well as families, friends, and contacts.
• Funding to enhance training of researchers and public health officials in theory, methods, and the importance of monitoring and addressing structural factors.
• Efforts to expand the understanding among policymakers of the importance of monitoring and addressing key modifiable structural factors as central components of the policy responses to the syndemic.
Novel structural variables have been examined in diverse settings that may be useful if applied to examinations of this syndemic. The US has experienced increased rates of foreclosures linked to the recession of 2008; surges in foreclosures are relevant "big events" [65] . Having undergone foreclosure oneself is associated with worse health outcomes, including not having filled prescriptions because of cost and depression [35, 90] . Living in an area with greater foreclosures is associated with increased individual-level rates of depression [65] . (Table 1) Recognizing that income inequality and race/ethnicity-based housing segregation may have a combined impact on populations, investigators have developed a measure termed the Index of Concentration at the Extremes (ICE) which examines both income inequality and segregation at area-levels [91] . It has been shown to be potently associated with several adverse health outcomes including infant mortality and hypertension [91] . There are no data examining the relationship between either foreclosures or the ICE and components of the sydnemic, but their sociologic plausibility suggest these may be important factors to be studied and addressed [19] .
Links between unemployment and public health outcomes, such as components of the syndemic, may occur through several of the mechanisms. One pathway is the link between employment and health insurance. A large proportion of the US population is insured through employer-provided plans; unemployment, temporary or part-time employment, and even full-time employment in certain sectors, may leave individuals without health insurance. Lack of health insurance is associated with increased overall mortality [92] . Specific to this syndemic, lack of health insurance serves as a barrier to engagement in MAT and HCV treatment and to delayed HIV diagnosis and treatment [60] [61] [62] 77] . (Table 2 ).
Interconnections Between National and International Policy and the Syndemic
One of the major successes in the global response to the HIV epidemic has been the expansion of ART. Critical to this expansion were policy changes, driven by social activism, facilitating access to generic medications. One threat to further ART expansion and a potential threat to the expansion of MAT and HCV treatment are elements of existing and proposed multi-national "trade deals" which could extend patents and restrict area-level access to generic medications [81, 93] .
These factors are not unrelated to the current US syndemic. Medicare Part D regulations include a prohibition against Medicare negotiating for lower than retail pricing, creating barriers in the form of co-payments by patients. Medicaid coverage for HCV treatment and MAT is highly variable by State, and remains constrained by patent-driven medication costs [94, 95] .
Structural Factors Are Addressable Through Intervention and Policy
There are a range of structural variables that are associated with, and maybe causal of, the components of the syndemic and impact the effectiveness of public health responses [7, 23] . Monitoring these factors can facilitate the identification of vulnerable areas and predict epidemiologic trends, and many are modifiable through public health interventions and policy changes [25, 46] . (Table 3 ) One form of structural intervention to improve the healthcare of PWUD is to recognize the multiplicity of co-existing risks and morbidities in the syndemic and to implement systems of integrated care rather than diseasespecific vertical care models [39] .
Enhanced structural competency may assist providers in recognizing structural barriers and coordinating responses to these. Expanding health insurance coverage is vital [23, 92] . Further, implementation of single payer or national health services, as has been done in other resourced countries, would solve many of these issues, not only removing lack of insurance as a "barrier," but directly addressing what should be viewed as an epidemic of the absence of health insurance; this would contribute substantially to disentangling one critical structural aspect of the current syndemic [92] .
As discussed, marketing can contribute to and cause opioid epidemics [68] . Recognizing this would suggest a need for tighter regulation by the FDA, and suggest the potential utility of public health monitoring of opioid marketing and distribution to predict upsurges in licit and illicit opioid use [8, 10] . A corollary of recognizing the contribution of marketing to the creation of opioid epidemics is that provider and pharmacist education will need to overcome marketing pressures, something more likely to be effectively accomplished through regulation of marketing than through an exclusive reliance on provider and pharmacist education and monitoring. Similar logic suggests a need for stronger regulations deterring potential conflicts in guidelines development.
Increasing restrictions on opioid marketing, distribution, and prescribing may contribute to primary prevention of opioid misuse, but for those already misusing opioids, it is critical that restrictions be accompanied by parallel increases in access to MAT, to avoid transitions to use of heroin, fentanyl, and IDU. There is substantial variability in the evidence-base for, and effectiveness of, OUD treatment interventions, with substantially more evidence for MAT than non-MAT treatments; therefore, expansion of OUD treatment should emphasize use of MAT [49, 50] . Further, experience with HIV epidemics and modeling suggest that combination prevention will also need to include expanded access to NSPs and naloxone training and distribution.
Communicating the Importance of Structural Factors to Policymakers
Unfortunately, while structural factors may be modifiable through public health intervention, the need to do so comes at a time when funding has languished; both public health and public healthcare funding streams remain at risk. There are unique dissemination issues with respect to information on structural determinants of health; qualitative studies have identified that policy makers (e.g., government officials) are commonly aware of these issues and of disparities among populations and regions [96] . However, they perceive them to be "complex issues," or frankly political issues, and policies that approach structural determinants often end up only offering individual-level solutions [96] [97] [98] . (Table 3) . Available data clearly demonstrate area-level structural vulnerability. Use of a continuum model depicting engagement in substance use screening, prevention and treatment could provide compelling depictions of addressable gaps in implementation [99, 100] .
Global Implications
Similar constellations of individual and structural factors fuel analogous syndemics in other countries. [43, 68] The global spread of IDU has been influenced by "globalization of both the licit and illicit drug industries" and the diffusion of people and technologies [41] . It would appear that this holds equally true for the syndemic, influenced by structural factors including economic inequality, unemployment, housing characteristics, trade agreements, and marketing. In fact, opioid manufacturers are currently eager to expand sales into Latin America, the Middle East, and Africa, and sales of prescription opioids are currently booming in China [101, 102] . As was done in the US, companies are employing many of the same marketing strategies including sponsoring seminars urging prescribers to overcome "opiophobia," again claiming rates of potential addiction are very low, and broadly promoting patented opioids rather than non-opioids or generic opioids for pain [43, 102] . With respect to this potential for the syndemic to grow internationally, former US Surgeon Vivak Murthy said "I would urge them to be very cautious of the marketing of these medications" [102] .
Conclusions
The US is in the midst of a syndemic of opioid misuse, overdose, HCV, and HIV. Recent data further demonstrate the links between these epidemics: significant national increases in the incidence of active HCV are strongly associated with increases in admissions for OUDs attributed to prescription opioids and heroin injection [103] . Structural factors contribute potently to creating the context that render individuals and areas vulnerable to the syndemic. Further recent data support the findings of Van Handel, et al. in demonstrating that structural factors, including per capita income, rates of opioid prescribing, and others, are predictive of HIV and HCV transmission [25, 104] . Recognizing these factors can facilitate the prediction and identification of areas at risk. Many of these structural factors are potentially modifiable through intervention and policy, with the potential to reduce structural vulnerability and create health enabling environments. Federal and state policy and funding need to explicitly support MAT and HCV treatment as well as ART, and to address other relevant structural factors such as marketing, economic and housing disparities, and criminal justice activity. Greater attention to issues of structural vulnerability by providers, public health officials, and likely most critically policy makers, is essential to formulating and implementing effective societal responses to the syndemic.
